Those who used GLP-1 agonists had a 14% lower risk of developing cirrhosis, a 22% lower risk of cirrhosis complications (decompensation, liver cancer or liver transplant) and an 11% lower risk of death from any cause
Which means inside your gut it breaks apart into the 3 amino acids it is made of
As tirzepatide (Mounjaro) belongs to the drug class of GLP-1 and GIP agonists, it mimics the activity of these hormones and initiates the following changes in the body: Increased Insulin Production: Mounjaro produces anti-diabetic effects by increasing insulin production in the body
Image Credit: KK Stock/Shutterstock.com Consequently, researchers are investigating new pharmacotherapies, including those that target the glucagon-like peptide-1 (GLP-1) system
However, if you are pregnant or planning to become pregnant, it's crucial to understand the safety implications of continuing or starting these medications
Always keep your provider informed about any other treatments or supplements youre taking